Ra Medical Systems Receives Approval in China for Pharos Dermatology Laser

This Week’s News in Review

This Week's News in Review! Medical Device News Magazine keeps our readers up-to-date on breaking industry news! Learn how Medical Device News Magazine can help...

New Research Shows Nearly Half of Elderly Suffer Decreased Mobility During Lockdown

In a survey of UK adults with parents over the age of 75, while over half (52%) of respondents remain worried about their parents catching Covid, 48 percent are concerned about parental loneliness, and 46 percent about their parents falling alone and not being able to get up or get help. This figure remained high even among those whose parents are in care homes, with 37% of respondents still most concerned about parents falling over.

American College of Cardiology Names Ravee Kurian COO/CFO

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

Ra Medical Systems Receives Approval in China for Pharos Dermatology Laser

Ra Medical Systems, Inc., makers of excimer lasers and catheters for cardiovascular and dermatological diseases, has received FDA (CFDA) approval for the Pharos Excimer Laser to treat psoriasis, vitiligo, and other skin diseases in The People’s Republic of China.

Ra Medical Systems is actively seeking distributors in China.

Pharos has more than a decade of proven clinical success in the United States, Middle East, and select markets in Asia, with millions of treatments performed.

Psoriasis is the second most common skin disorder which affects approximately 1 in every 49 people, or about 2.02% of the population.

Approval in China widens Pharos’ geographic scope and opens new opportunity to provide best-in-class therapy for China’s estimated 26 million psoriasis sufferers.

It also gives new hope to China’s estimated 13 million vitiligo patients, many of whom have been told there are no treatment options for their disease.

“2017 will be a pivotal year for Ra Medical Systems’ dermatology division as we capitalize on the approvals to sell Pharos in China and the European Union. The CFDA approval in China and CE mark for Europe set the stage for helping millions of patients and driving growth for the company,” said co-founder and CEO Dean Irwin.

“Medicine is modernizing in China, new hospitals and clinics are opening up, and millions of dermatology patients are gaining access to treatment for their diseases for the first time in their lives. The Pharos is now in China, at the right time, in the right place,” added Jeffrey Kraws, President.

spot_img

DON'T MISS

Dr Jonathan Slotkin Appointed to Peer Well Board of Directors

Alongside the appointment, PeerWell is launching its new clinical practice, PeerWell Health.

Zimmer Biomet Announces New Appointments to Executive Leadership Team

Wilfred van Zuilen Appointed as President of Europe, Middle East and Africa. Nitin Goyal, M.D. Appointed to Newly Created Role of Chief Science, Technology and Innovation Officer.

Subscribe to Medical Device News Magazine here.

Related Articles